Zygem Corp. and the US Army Medical Research Institute of Infectious Diseases have signed a CRADA for the development of simplified sample processing solutions for biothreat agents.
They will collaborate on the development, testing and validation of new solutions for the rapid and efficient extraction of DNA and other nucleic acids for the detection of biothreat agents and other pathogens from a variety of samples.
This effort leverages ZyGEM's proprietary DNA extraction technology, which uses thermophilic enzymes, to provide sample processing capabilities for the detection of a variety of biothreat agents and for use in challenging environments.
